Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Neurotrophin signaling pathway	7/119	1.4588888119928622e-11	1.5610110288323626e-09	165.75	-411.94914049648423	BRAF;HRAS;KRAS;MAP2K7;PTPN11;RAF1;SOS1
KEGG_2021_Human	Renal cell carcinoma	6/69	6.362284067331453e-11	3.4038219760223276e-09	190.5952380952381	-458.23071562132344	BRAF;HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	Chronic myeloid leukemia	6/76	1.1568130777763957e-10	4.125966644069145e-09	171.38571428571427	-430.8222663769055	BRAF;HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	ErbB signaling pathway	6/85	2.3053411761684828e-10	6.166787646250692e-09	151.68987341772151	-399.03299278264757	BRAF;HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	6/131	3.22986834076209e-09	6.911918249230873e-08	95.316	-285.46143465447136	BRAF;HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	Endometrial cancer	5/58	3.924235171479762e-09	6.99821938913891e-08	151.22641509433961	-357.01450658069916	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Fc epsilon RI signaling pathway	5/68	8.88126377354054e-09	1.0558835819653754e-07	127.06349206349206	-315.4298190501735	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	MAPK signaling pathway	7/294	8.613842285651333e-09	1.0558835819653754e-07	63.260162601626014	-208.07497507114164	BRAF;HRAS;KRAS;MAP2K7;NF1;RAF1;SOS1
KEGG_2021_Human	Acute myeloid leukemia	5/67	8.23250285323093e-09	1.0558835819653754e-07	129.1290322580645	-319.121405242259	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Non-small cell lung cancer	5/72	1.1895933602685599e-08	1.1571499049885083e-07	119.41791044776119	-301.5255310007327	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Hepatitis B	6/162	1.1657637504621833e-08	1.1571499049885083e-07	76.07692307692308	-238.99790749378803	BRAF;HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	Glioma	5/75	1.4651480307214275e-08	1.3064236607266062e-07	114.25714285714285	-291.91790397658275	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Colorectal cancer	5/86	2.9395451563588622e-08	2.419471782541525e-07	98.60493827160494	-261.58735105388666	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	GnRH signaling pathway	5/93	4.370736564994153e-08	3.340491517531246e-07	90.68181818181819	-245.48357760337638	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	Proteoglycans in cancer	6/205	4.7926693983978674e-08	3.4187708375238125e-07	59.314070351758794	-194.8140421725905	BRAF;HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	Prostate cancer	5/97	5.4085780869589264e-08	3.616986595653782e-07	86.69565217391305	-237.1712976551275	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	T cell receptor signaling pathway	5/104	7.689793164389816e-08	4.840046285821826e-07	80.4949494949495	-223.94034919826578	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	Ras signaling pathway	6/232	1.0038183269047773e-07	5.96714227660062e-07	52.04867256637168	-174.3857646205266	HRAS;KRAS;NF1;PTPN11;RAF1;SOS1
KEGG_2021_Human	Bladder cancer	4/41	1.1734085699248772e-07	6.608142999050624e-07	144.7027027027027	-280.59591734901187	BRAF;HRAS;KRAS;RAF1
KEGG_2021_Human	Relaxin signaling pathway	5/129	2.2716633239535927e-07	1.2153398783151721e-06	64.06451612903226	-186.88656585734114	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	FoxO signaling pathway	5/131	2.453717102706871e-07	1.2502272856649296e-06	63.03174603174603	-184.44906174375365	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Insulin signaling pathway	5/137	3.070399768694536e-07	1.4933307965923425e-06	60.121212121212125	-177.50304940933535	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Gastric cancer	5/149	4.670966590157567e-07	1.9991737005874387e-06	55.02777777777778	-165.06046920792772	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Breast cancer	5/147	4.366280429620726e-07	1.9991737005874387e-06	55.816901408450704	-167.01315353572727	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Phospholipase D signaling pathway	5/148	4.5165846521694494e-07	1.9991737005874387e-06	55.41958041958042	-166.03116096912797	HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	mTOR signaling pathway	5/154	5.506914925979601e-07	2.2139028208595603e-06	53.147651006711406	-160.36960249388903	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Long-term depression	4/60	5.586483753570852e-07	2.2139028208595603e-06	95.38095238095238	-208.2793311948127	BRAF;HRAS;KRAS;RAF1
KEGG_2021_Human	Hepatitis C	5/157	6.062762738655014e-07	2.3168414751288805e-06	52.078947368421055	-157.67845628585505	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Long-term potentiation	4/67	8.744364582866104e-07	3.1188233678889105e-06	84.70899470899471	-190.62775527188097	BRAF;HRAS;KRAS;RAF1
KEGG_2021_Human	Hepatocellular carcinoma	5/168	8.493017345096659e-07	3.1188233678889105e-06	48.49693251533742	-148.5218030993381	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Prolactin signaling pathway	4/70	1.044163095458912e-06	3.6040468133581806e-06	80.82828282828282	-183.98664919066243	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Melanoma	4/72	1.1701896109043542e-06	3.912821511461435e-06	78.43137254901961	-179.82105034024002	BRAF;HRAS;KRAS;RAF1
KEGG_2021_Human	Alcoholism	5/186	1.407749997169483e-06	4.56452271809499e-06	43.574585635359114	-135.57193930898038	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Chemokine signaling pathway	5/192	1.6475564077590864e-06	5.184956930300655e-06	42.144385026737964	-131.72377772149218	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	B cell receptor signaling pathway	4/81	1.8822504670820177e-06	5.7543085707935975e-06	69.18614718614718	-163.26311048820392	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Gap junction	4/88	2.627125268929808e-06	7.808400104874708e-06	63.36507936507937	-152.4012036590114	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	4/89	2.7491085630604124e-06	7.950124763444977e-06	62.61176470588235	-150.9687540546772	HRAS;KRAS;PTPN11;RAF1
KEGG_2021_Human	Regulation of actin cytoskeleton	5/218	3.086152382817006e-06	8.68995539372157e-06	36.87793427230047	-117.19031279125306	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Choline metabolism in cancer	4/98	4.045325673294005e-06	1.1098714026729706e-05	56.5531914893617	-139.20816886591868	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	C-type lectin receptor signaling pathway	4/104	5.130876847568527e-06	1.372509556724581e-05	53.12	-132.3420645012429	HRAS;KRAS;PTPN11;RAF1
KEGG_2021_Human	Serotonergic synapse	4/113	7.1460852432057485e-06	1.864953953714671e-05	48.678899082568805	-123.22339060338247	BRAF;HRAS;KRAS;RAF1
KEGG_2021_Human	Growth hormone synthesis, secretion and action	4/119	8.781438908516766e-06	2.237176102884033e-05	46.10434782608696	-117.80575201518995	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Thyroid cancer	3/37	1.0384632752750053e-05	2.5840830338238505e-05	101.26890756302521	-158.85054794063166	BRAF;HRAS;KRAS
KEGG_2021_Human	Estrogen signaling pathway	4/137	1.5363738345825308e-05	3.736181825007518e-05	39.774436090225564	-104.03256013781805	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	JAK-STAT signaling pathway	4/162	2.979383554686203e-05	7.084312007809415e-05	33.37552742616034	-89.36652156273904	HRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	Alzheimer disease	5/369	4.0340680197942286e-05	9.383593002564836e-05	21.164835164835164	-69.66216524591873	BRAF;HRAS;KRAS;MAP2K7;RAF1
KEGG_2021_Human	VEGF signaling pathway	3/59	4.2829644076396207e-05	9.750578545051902e-05	61.316326530612244	-109.395777314067	HRAS;KRAS;RAF1
KEGG_2021_Human	Axon guidance	4/182	4.708801155471762e-05	0.00010496702575739136	29.55056179775281	-80.18631081942894	HRAS;KRAS;PTPN11;RAF1
KEGG_2021_Human	GnRH secretion	3/64	5.4712305971300705e-05	0.00011947381099855461	56.25526932084309	-102.29382199022506	HRAS;KRAS;RAF1
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	4/193	5.926501543349045e-05	0.00012682713302766957	27.79188712522046	-75.84859252655446	HRAS;KRAS;MAP2K7;RAF1
KEGG_2021_Human	Focal adhesion	4/201	6.947038219704022e-05	0.000145751586178104	26.63620981387479	-72.95515241997339	BRAF;HRAS;RAF1;SOS1
KEGG_2021_Human	Central carbon metabolism in cancer	3/70	7.160249860764975e-05	0.00014733591059651007	51.17910447761194	-94.92366080084827	HRAS;KRAS;RAF1
KEGG_2021_Human	Rap1 signaling pathway	4/210	8.243152623376804e-05	0.00016641836428326755	25.44336569579288	-69.93123366666362	BRAF;HRAS;KRAS;RAF1
KEGG_2021_Human	Human immunodeficiency virus 1 infection	4/212	8.553680416035766e-05	0.00016948959342885688	25.192307692307693	-69.28980198257669	HRAS;KRAS;MAP2K7;RAF1
KEGG_2021_Human	Pancreatic cancer	3/76	9.159620399517935e-05	0.00017819625140880348	46.93737769080235	-88.55605413655218	BRAF;KRAS;RAF1
KEGG_2021_Human	Human cytomegalovirus infection	4/225	0.00010785574304042276	0.00020608150902366493	23.671191553544496	-65.36509727839072	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Chemical carcinogenesis	4/239	0.00013636702582860217	0.0002515736510975937	22.22127659574468	-61.560372574383265	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Pathways of neurodegeneration	5/475	0.00013552707217441697	0.0002515736510975937	16.16595744680851	-52.849354173241736	BRAF;HRAS;KRAS;MAP2K7;RAF1
KEGG_2021_Human	Progesterone-mediated oocyte maturation	3/100	0.00020740615092509237	0.00037614335845737094	35.2179675994109	-69.8003308229761	BRAF;KRAS;RAF1
KEGG_2021_Human	Melanogenesis	3/101	0.00021361559897150326	0.00038094781816584754	34.85422740524781	-69.18688807277512	HRAS;KRAS;RAF1
KEGG_2021_Human	Pathways in cancer	5/531	0.00023006625856898829	0.00040355884699806146	14.338403041825096	-46.44758767649085	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Sphingolipid signaling pathway	3/119	0.0003468783323520502	0.0005986448638978931	29.379310344827587	-59.68521503911596	HRAS;KRAS;RAF1
KEGG_2021_Human	Thyroid hormone signaling pathway	3/121	0.00036434044298052937	0.0006188004349034389	28.87409200968523	-58.78131250266827	HRAS;KRAS;RAF1
KEGG_2021_Human	MicroRNAs in cancer	4/310	0.00037183876854062896	0.000621667941153864	16.910675381263616	-47.03626387241228	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Human papillomavirus infection	4/331	0.0004777466484480537	0.0007864444828298731	15.781855249745158	-43.81753827074924	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Apelin signaling pathway	3/137	0.0005248515914701949	0.0008381958251837442	25.375266524520256	-52.38188378130509	HRAS;KRAS;RAF1
KEGG_2021_Human	Autophagy	3/137	0.0005248515914701949	0.0008381958251837442	25.375266524520256	-52.38188378130509	HRAS;KRAS;RAF1
KEGG_2021_Human	Apoptosis	3/142	0.0005829830335043062	0.0009173409497788349	24.447070914696813	-50.640785217242495	HRAS;KRAS;RAF1
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	3/143	0.0005950854077497673	0.000922813603322103	24.26938775510204	-50.30529409222555	HRAS;KRAS;RAF1
KEGG_2021_Human	PI3K-Akt signaling pathway	4/354	0.0006170414755932672	0.0009431919698354227	14.700952380952382	-40.688114366493096	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Oxytocin signaling pathway	3/154	0.0007390260491982426	0.0011137434825945348	22.47019867549669	-46.86692877135684	HRAS;KRAS;RAF1
KEGG_2021_Human	Cellular senescence	3/156	0.0007673816433603202	0.001140414386660476	22.170868347338935	-46.2873867313738	HRAS;KRAS;RAF1
KEGG_2021_Human	Lipid and atherosclerosis	3/215	0.0019428303639941794	0.0028477102595531123	15.881401617250674	-33.55383703082171	HRAS;KRAS;MAP2K7
KEGG_2021_Human	Thermogenesis	3/232	0.0024164136009215383	0.0034940034499811434	14.670617592014972	-30.966105875434415	HRAS;KRAS;SOS1
KEGG_2021_Human	Salmonella infection	3/249	0.0029568377027043165	0.004218421789191492	13.627177700348431	-28.69609856443984	HRAS;MAP2K7;RAF1
KEGG_2021_Human	Mitophagy	2/68	0.0030081604419031007	0.004235173253731997	30.310606060606062	-38.524679686703344	HRAS;KRAS
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.008893198299055929	20.331632653061224	-27.120602948412195	HRAS;KRAS
KEGG_2021_Human	Longevity regulating pathway	2/102	0.006650847322673755	0.00912359825033451	19.92	-26.61700675496218	HRAS;KRAS
KEGG_2021_Human	Parathyroid hormone synthesis, secretion and action	2/106	0.0071664154144845515	0.009706410751263887	19.14423076923077	-25.65956234303792	BRAF;RAF1
KEGG_2021_Human	Cholinergic synapse	2/113	0.008111349626545349	0.010848930125504405	17.92117117117117	-24.127023560492017	HRAS;KRAS
KEGG_2021_Human	Vascular smooth muscle contraction	2/133	0.011103972768351109	0.014668210940908255	15.146946564885496	-20.537590301958808	BRAF;RAF1
KEGG_2021_Human	Viral carcinogenesis	2/203	0.024762333575826773	0.0323118255196764	9.784825870646767	-13.073912909097736	HRAS;KRAS
KEGG_2021_Human	cAMP signaling pathway	2/216	0.027803609837697526	0.03584320786305585	9.175233644859814	-12.174459052502558	BRAF;RAF1
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	2/219	0.028526440921903908	0.036337252126710934	9.044930875576037	-11.980722307867735	HRAS;KRAS
KEGG_2021_Human	Aldosterone-regulated sodium reabsorption	1/37	0.04489527895199197	0.05651523350427225	24.790123456790123	-13.876145105511855	KRAS
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.1023364174756484	13.071895424836601	-7.854937277937848	PTPN11
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.10256945748008085	12.880837359098228	-7.74542097629872	PTPN11
KEGG_2021_Human	Fc gamma R-mediated phagocytosis	1/97	0.11385418156418702	0.13843633440190922	9.226851851851851	-5.553951626329874	RAF1
KEGG_2021_Human	Toll-like receptor signaling pathway	1/104	0.12160016340314761	0.14619345487794153	8.592233009708737	-5.152341092635986	MAP2K7
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.14979884353284426	8.2668743509865	-4.943743954376122	PTPN11
KEGG_2021_Human	TNF signaling pathway	1/112	0.13037805537365837	0.15330166950529062	7.964964964964965	-4.748494648054986	MAP2K7
KEGG_2021_Human	Leukocyte transendothelial migration	1/114	0.13256015588280526	0.1541732247767409	7.822025565388397	-4.655477238055189	PTPN11
KEGG_2021_Human	Osteoclast differentiation	1/127	0.1466241030974613	0.16869654872503612	7.00352733686067	-4.115510268264927	MAP2K7
KEGG_2021_Human	Yersinia infection	1/137	0.15730251033809037	0.17905711283165607	6.480392156862745	-3.763669230249352	MAP2K7
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.15942370386618251	0.1795614348808582	6.384863123993559	-3.698840756963446	MAP2K7
KEGG_2021_Human	Cushing syndrome	1/155	0.17622102470306392	0.19641301711695666	5.70995670995671	-3.235678410841787	BRAF
KEGG_2021_Human	Influenza A	1/172	0.1937366175133076	0.2072981807392391	5.131254061078622	-2.8313674486945275	RAF1
KEGG_2021_Human	cGMP-PKG signaling pathway	1/167	0.1886201000678787	0.2072981807392391	5.289156626506024	-2.942334294710352	RAF1
KEGG_2021_Human	Tight junction	1/169	0.19067020323006928	0.2072981807392391	5.224867724867725	-2.8972129419331236	MAP2K7
KEGG_2021_Human	Protein processing in endoplasmic reticulum	1/171	0.19271564324144907	0.2072981807392391	5.162091503267974	-2.8530763101358976	MAP2K7
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.2138545110074202	4.896958410924891	-2.6658400097237527	RAF1
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.2212553470212389	4.657210401891253	-2.4954112144854435	RAF1
KEGG_2021_Human	Pathogenic Escherichia coli infection	1/197	0.21888628489075546	0.22738672313894012	4.462585034013605	-2.3563138595912863	PTPN11
KEGG_2021_Human	Epstein-Barr virus infection	1/202	0.22383065271253133	0.23028730615616205	4.3488114980652295	-2.274707784911856	MAP2K7
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.2769236461027586	3.4603806994245243	-1.6315316807371463	HRAS
KEGG_2021_Human	Huntington disease	1/306	0.32049274018188956	0.3235162565986998	2.8280510018214935	-1.1715156192121785	MAP2K7
KEGG_2021_Human	Herpes simplex virus 1 infection	1/498	0.4709527127104428	0.4709527127104428	1.6926000447127207	-0.379898711570649	PTPN11
